CasLoc logo
All Cases PTAB Litigations UPC Oppositions

AstraZeneca UK Limited v. Watson Pharmaceuticals Inc.

1:10-cv-00915

Overview

Case Number 1:10-cv-00915
Filing Date 2010-10-26
Status Terminated
Termination Date 2013-03-26
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Watson Laboratories Inc. (CT) Operating Company

Represented By

1 Attorneys Listed

David Ellis Moore

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

Watson Laboratories Inc. (NY) Operating Company

Represented By

1 Attorneys Listed

David Ellis Moore

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

Watson Laboratories Inc. (DE) Operating Company

Represented By

1 Attorneys Listed

David Ellis Moore

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

Watson Laboratories Inc. - Florida Operating Company

Represented By

1 Attorneys Listed

David Ellis Moore

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

Plaintiff

Shionogi Seiyaku Kabushiki Kaisha Operating Company

Represented By

3 Attorneys Listed

IPR Pharmaceuticals Inc. Operating Company

Represented By

4 Attorneys Listed

AstraZeneca UK Limited NPE (University / Research)

Represented By

9 Attorneys Listed

Counter Claimant

EGIS Pharmaceuticals PLC NPE (Individual / Inventor)

Represented By

3 Attorneys Listed

David Ellis Moore

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

Watson Laboratories Inc. (NV) Operating Company

Represented By

6 Attorneys Listed

David Ellis Moore

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

Watson Pharma Inc. Operating Company

Represented By

1 Attorneys Listed

David Ellis Moore

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

Watson Pharmaceuticals Inc. Operating Company

Represented By

1 Attorneys Listed

David Ellis Moore

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts 9 proceedings
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Parallel Proceedings Across Jurisdictions (9 found):
U.S. Courts: 9
U.S. District Court 2013-12-09
2:13-cv-03438

MUSC Foundation for Research Development v. AstraZeneca Pharmaceuticals LP

Asserted Patent
Status: SCD
U.S. District Court 2013-07-31
2:13-cv-02078

MUSC Foundation for Research Development v. AstraZeneca Pharmaceuticals LP

Asserted Patent
Status: SCD
U.S. District Court 2011-04-05
2:11-cv-00807

Palmetto Pharmaceuticals LLC v. AstraZeneca Pharmaceuticals LP

Asserted Patent
Status: SCD
U.S. District Court 2010-04-26
1:10-cv-00341

AstraZeneca Pharmaceuticals LP v. Glenmark Generics Inc. USA

Asserted Patent
Status: DED
U.S. District Court 2010-04-26
1:10-cv-00345

AstraZeneca Pharmaceuticals LP v. Sun Pharmaceutical Industries Ltd.

Asserted Patent
Status: DED
U.S. District Court 2010-04-26
1:10-cv-00343

AstraZeneca Pharmaceuticals LP v. Par Pharmaceutical Inc.

Asserted Patent
Status: DED
U.S. District Court 2010-04-26
1:10-cv-00344

AstraZeneca Pharmaceuticals LP v. Sandoz Inc.

Asserted Patent
Status: DED
U.S. District Court 2010-04-26
1:10-cv-00339

AstraZeneca Pharmaceuticals LP v. Aurobindo Pharma Limited

Asserted Patent
Status: DED
U.S. District Court 2010-04-26
1:10-cv-00342

AstraZeneca Pharmaceuticals LP v. Mylan Pharmaceuticals Inc.

Asserted Patent
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

4 Patents

There are 4 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
USRE37314
Pyrimidine derivatives
Filed: 1998-08-27
Issued: 2001-08-07
Expired (Term Ended)
Expires: 2016-01-08
US6858618
Use of rosuvastatin (zd-4522) in the treatment of heterozygous familial hypercholesterolemia
Filed: 2001-11-16
Issued: 2005-02-22
Expired (Term Ended) +31d PTA
Expires: 2021-12-17
US7030152
Systematic inflammatory markers as diagnostic tools in the prevention of atherosclerotic diseases and as tools to aid in the selection of agents to be used for the prevention and treatment of atherosclerotic disease
Filed: 1999-08-31
Issued: 2006-04-18
Expired (Term Ended)
Expires: 2019-08-31
US6316460
Pharmaceutical compositions
Filed: 2000-08-04
Issued: 2001-11-13
Expired (Term Ended)
Expires: 2020-08-04

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Statutorily Barred

Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting truncation noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

110

Dispositive

39

Granted

0

Denied

0

Pending / Review

110

Motions by Category

Procedural / Extension Motion 41 Claim Construction / Markman Filing 30 Motion to Dismiss (FRCP 12(b)(6)) 10 Motion to Dismiss 13 Motion for Summary Judgment (Infringement) 16

Key Dispositive Motions & Rulings

Motion for Summary Judgment (Infringement) Pending / Under Review
ORDER re 373 Memorandum Opinion -- 283 MOTION for Summary Judgment Of No Infringement Under The Doctrine Of Equivalents filed by Watson Laboratories Inc. (NV); ...
Entry #374 • 2012-11-14 Document →
Motion for Summary Judgment (Infringement) Pending / Under Review
REDACTED VERSION of 332 SEALED MOTION for Leave to File DEFENDANT WATSON LABORATORIES, INC. (NV)'S UNOPPOSED MOTION FOR LEAVE TO FILE A RESPONSE TO PLAINTIFFS' ...
Entry #336 • 2012-08-07 Document →
Motion for Summary Judgment (Infringement) Pending / Under Review
REDACTED VERSION of 333 Reply to Response to Motion, RESPONSE TO SUR-REPLY IN SUPPORT OF DEFENDANT WATSON LABORATORIES, INC. (NV)'S MOTION FOR SUMMARY JUDGMENT ...
Entry #337 • 2012-08-07 Document →
Motion for Summary Judgment (Infringement) Pending / Under Review
SEALED REPLY to Response to Motion re 283 MOTION for Summary Judgment Of No Infringement Under The Doctrine Of Equivalents [RESPONSE TO SUR-REPLY IN SUPPORT OF ...
Entry #333 • 2012-08-03 Document →
Motion for Summary Judgment (Infringement) Pending / Under Review
SEALED MOTION for Leave to File DEFENDANT WATSON LABORATORIES, INC. (NV)'S UNOPPOSED MOTION FOR LEAVE TO FILE A RESPONSE TO PLAINTIFFS' SUR-REPLY REGARDING SUMM...
Entry #332 • 2012-07-31 Document →
Motion for Summary Judgment (Infringement) Pending / Under Review
REDACTED VERSION of 314 Reply Brief re 283 MOTION for Summary Judgment Of No Infringement Under The Doctrine Of Equivalents by Watson Laboratories Inc. (NV). (M...
Entry #322 • 2012-07-10 Document →

Docket Entries

(438 total)
Pleading / Complaint

COMPLAINT filed against Watson Laboratories Inc. (CT), Watson Laboratories Inc. (DE), Watson Laboratories Inc. (NV), Watson Laboratories Inc. (NY), Watson Laboratories Inc. - Florida, Watson Pharma Inc., Watson Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 311-800421.) - filed by Shionogi Seiyaku Kabushiki Kaisha, AstraZeneca UK Limited, IPR Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(dmp, ) (Entered: 10/27/2010)

Entry #1 • 2010-10-26
1
Pleading / Complaint

COMPLAINT filed against Watson Laboratories Inc. (CT), Watson Laboratories Inc. (DE), Watson Laboratories Inc. (NV), Watson Laboratories Inc. (NY), Watson Laboratories Inc. - Florida, Watson Pharma Inc., Watson Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 311-800421.) - filed by Shionogi Seiyaku Kabushiki Kaisha, AstraZeneca UK Limited, IPR Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(dmp, ) (Entered: 10/27/2010)

Entry #1 • 2010-10-26
2
Pleading / Complaint

COMPLAINT filed against Watson Laboratories Inc. (CT), Watson Laboratories Inc. (DE), Watson Laboratories Inc. (NV), Watson Laboratories Inc. (NY), Watson Laboratories Inc. - Florida, Watson Pharma Inc., Watson Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 311-800421.) - filed by Shionogi Seiyaku Kabushiki Kaisha, AstraZeneca UK Limited, IPR Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(dmp, ) (Entered: 10/27/2010)

Entry #1 • 2010-10-26
2

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction (dmp, ) (Entered: 10/27/2010)

Entry #2 • 2010-10-26
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US RE37,314 E; (dmp, ) (Entered: 10/27/2010)

Entry #3 • 2010-10-26
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc